Forte Biosciences (FBRX) Reports In-Line Q1 EPS

Forte Biosciences (NASDAQ: FBRX) reported Q1 EPS of ($0.16), in-line with the analyst estimate of ($0.16).

For earnings history and earnings-related data on Forte Biosciences (FBRX) click here.

You May Also Be Interested In

• Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
• Morgan Stanley Resumes Gap, Inc. (GAP) at Equalweight
• AbbVie updates 2026 EPS guidance after $291M IPR&D charge